Crossmark

Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2014.02.009

Published Print: 2016-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Boada, M.

Ramos-Fernández, E.

Guivernau, B.

Muñoz, F.J.

Costa, M.

Ortiz, A.M.

Jorquera, J.I.

Núñez, L.

Torres, M.

Páez, A.
License Information

Text and Data Mining valid from 2016-09-01

Version of Record valid from 2016-12-31
More Information

This article is maintained by: Elsevier

Article Title: Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2014.02.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2014.02.003

Content Type: article

Copyright: © 2014 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below